Borosil Scientific Limited (BOM:544184)
India · Delayed Price · Currency is INR 109.95
-1.20 (-1.08%)
At close: Nov 9, 2026
Borosil Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 4,862 | 4,673 | 4,385 | 3,960 | 980.43 | 1,062 |
Other Revenue | - | - | - | - | 3.65 | 2.32 |
| 4,862 | 4,673 | 4,385 | 3,960 | 984.08 | 1,064 | |
Revenue Growth | 12.07% | 6.58% | 10.73% | 302.39% | -7.54% | 62.73% |
Cost of Revenue | 1,696 | 1,701 | 1,639 | 1,469 | 444.72 | 473.04 |
Gross Profit | 3,166 | 2,973 | 2,746 | 2,491 | 539.37 | 591.27 |
Selling, General & Admin | 911.47 | 879.74 | 840.18 | 794.6 | 138.03 | 131.93 |
Other Operating Expenses | 1,562 | 1,463 | 1,378 | 1,228 | 305.91 | 288.93 |
Operating Expenses | 2,670 | 2,535 | 2,403 | 2,187 | 514.58 | 482.58 |
Operating Income | 495.65 | 437.26 | 343.09 | 304.15 | 24.79 | 108.7 |
Interest Expense | -9.88 | -11.28 | -15.46 | -27.02 | -3.28 | -3.12 |
Interest & Investment Income | 15.65 | 15.65 | 39.59 | 24.65 | 0.74 | 0.37 |
Currency Exchange Gain (Loss) | -0.88 | -0.88 | 2 | 5.41 | 1.07 | 2.16 |
Other Non Operating Income (Expenses) | 70.85 | 70.78 | 34.5 | 6.49 | 3.54 | 4.55 |
EBT Excluding Unusual Items | 571.39 | 511.53 | 403.73 | 313.68 | 26.86 | 112.66 |
Merger & Restructuring Charges | - | -66.13 | - | - | - | - |
Gain (Loss) on Sale of Investments | 6.36 | 6.36 | 1.62 | 2.45 | 3.06 | 0.55 |
Gain (Loss) on Sale of Assets | -5.71 | -5.71 | -1.43 | -0.72 | -0.18 | - |
Other Unusual Items | -19.15 | -19.15 | - | - | - | - |
Pretax Income | 554.44 | 428.45 | 403.91 | 315.51 | 29.74 | 113.2 |
Income Tax Expense | 98.38 | 82.63 | 136.68 | 80.7 | 9.1 | 27.53 |
Earnings From Continuing Operations | 456.05 | 345.81 | 267.23 | 234.82 | 20.64 | 85.68 |
Minority Interest in Earnings | -0.37 | 0.32 | 0.81 | 0.77 | - | - |
Net Income | 455.69 | 346.14 | 268.04 | 235.59 | 20.64 | 85.68 |
Net Income to Common | 455.69 | 346.14 | 268.04 | 235.59 | 20.64 | 85.68 |
Net Income Growth | 289.42% | 29.14% | 13.78% | 1041.24% | -75.91% | 598.02% |
Shares Outstanding (Basic) | 88 | 89 | 89 | 89 | 2 | 1 |
Shares Outstanding (Diluted) | 88 | 89 | 89 | 89 | 2 | 1 |
Shares Change | -2.16% | 0.15% | 0.13% | 5334.22% | 12.33% | 4.08% |
EPS (Basic) | 5.18 | 3.89 | 3.02 | 2.65 | 12.64 | 58.94 |
EPS (Diluted) | 5.18 | 3.89 | 3.02 | 2.65 | 12.64 | 58.94 |
EPS Growth | 298.06% | 28.95% | 13.84% | -79.03% | -78.55% | 570.67% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 141.61 | 148.18 | 1,059 | 171.27 | -223.9 | -39.44 |
Free Cash Flow Per Share | 1.61 | 1.67 | 11.91 | 1.93 | -137.11 | -27.13 |
Gross Margin | 65.11% | 63.61% | 62.63% | 62.91% | 54.81% | 55.55% |
Operating Margin | 10.20% | 9.36% | 7.82% | 7.68% | 2.52% | 10.21% |
Profit Margin | 9.37% | 7.41% | 6.11% | 5.95% | 2.10% | 8.05% |
Free Cash Flow Margin | 2.91% | 3.17% | 24.14% | 4.32% | -22.75% | -3.71% |
EBITDA | 681.69 | 619.09 | 511.64 | 452.35 | 95.43 | 170.4 |
EBITDA Margin | 14.02% | 13.25% | 11.67% | 11.42% | 9.70% | 16.01% |
D&A For EBITDA | 186.04 | 181.82 | 168.55 | 148.21 | 70.64 | 61.71 |
EBIT | 495.65 | 437.26 | 343.09 | 304.15 | 24.79 | 108.7 |
EBIT Margin | 10.20% | 9.36% | 7.82% | 7.68% | 2.52% | 10.21% |
Effective Tax Rate | 17.75% | 19.29% | 33.84% | 25.58% | 30.58% | 24.32% |
Revenue as Reported | 4,957 | 4,769 | 4,463 | 4,000 | 992.49 | 1,072 |
Advertising Expenses | - | - | - | - | 5.19 | 2.82 |